NCT01511393Enrolling by invitation
An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)
Medullary Thyroid Carcinoma Surveillance Study: A Case-Series Registry
Source: ClinicalTrials.gov · Last updated 13 Jun 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study is conducted in the United States of America (USA). The aim of the study is to monitor the number of annual new adult cases of medullary thyroid carcinoma (MTC) and to establish a registry for these new cases in order to identify any possible increase related to the introduction of liraglutide, exenatide once-weekly, and other GLP-1 receptor agonists into the US market.
- Status (registry)
- Enrolling by invitation
- Study type
- Observational
- Enrollment
- 6750 (estimated)
- First submitted
- 30 Nov 2011
- Start date
- Jan 2012
- Primary completion date
- Dec 2039
- Lead sponsor
- Novo Nordisk A/S
- Diseases
- Thyroid cancer, Type 2 diabetes
- NCT number
- NCT01511393
What you commit to
- Study type: Observational
- Planned participants: 6750
- From Jan 2012 to the primary completion date, Dec 2039
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- A record of medullary thyroid carcinoma (MTC) identified from state/regional population-based cancer registries
- At least 18 years or older.
- There are no other inclusion or exclusion criteria.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| United BioSource LLC Coordinator of this site? Confirm its status | Morgantown | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.